Glauconix Biosciences names new chief operating officer
7 August 2019 -

Glauconix Biosciences Inc, a specialty pharmaceutical company, announced yesterday that it has named Kimberly Southern as its new chief operating officer.

Southern has more than 20 years of experience in building and leading companies in various industries, most recently as COO at New England Peptide in Gardner, Massachusetts.

In her new role, she will steer the company's business strategies, drive operational execution, and further develop the company's R&D initiatives and intellectual property portfolio.

Glauconix is located on the SUNY Polytechnic Institute Campus in Albany, which is affiliated with the Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2).